2Abramson AL, Waner M, Bradsma J. The clinical treatment of laryngeal papillomas with hematoporphyrin therapy[J]. Arch Otolaryngol Head Neck Surg, 1988,114: 795.
3Shikowitz MJ, Steinberg BM, Galli RL. Histological and molecular analysis of cottontail rabbit papillomavirus-induced papillomas treated with hematoporphy in derivative photodynamic therapy[J]. Arch Otolaryngol Head Neck Surg, 1988,114(2) : 175.
4Abramson AL, Shikowitz M J, Mullooly VM, et al Clinical effects of photodynamic therapy on recurrent laryngeal papillomas[J]. Arch Otolaryngol Head Neck Surg, 1992, 118:25.
8Yang CH, Lee JC, Chen CH, et al. Photodynamic therapy for bowenoid papulosis using a novel incoherent lightemitting diodedevice[J]. Br J Dermatol, 2003,149 : 1297.
9Benhur E, Oetjen J, Harowitz B. Sillcon phthalocyamine Pc4 and red light causes apoptosis in HIV-infected cells [J]. Photochem Photobiol, 1997,65 (3) : 456.
4[1]Ochsner M.Photodynamic therapy:the clinical perspective.Review on applications for control of diverse tumorous and non-tumorous diseases[J].Arzneimittelforschung,1997,47:1185～1194.
5[2]LatkowskiB.Use of sensitizers and photo laser for diagnosis and treatment of malignant tumors.Otolarynpol pol,1995,49[20]:205～208.
6[3]Fingar VH,Kik PK,Haydon PS,et al.Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative(BPD).Br-J-Cancer.1999 APR:79(11)1702.
7[4]Engbrecht BW,Wenon C,Kachur AV,et al.Photofrin-mediated photodynamic therapy induced vascular occlusion and apoptosis in a human sarcoma xenograft model.Cancer-Res.1999SEP 1;59(17):4334～4342.
8[5]Webber J,Herman m,Kessel D,et al.Photodynamic treatment of neoplastic lesions of the gastrointestinal tract.Langenbecks-Arch-Surg.2000JUL;385(4):299～304.
9[6]Oleinick NL,Evans HH.The photodynamic therapy:cellular targets and mechanisms[J].Radiat Res,1998,150(5):S146～156.
10[7]Chiu SM,Oleinick NL.Dissociation of mitochondyial depolarization from cytochrome c crelease during apoptosis induced by photodynamic therapy.Br-J-Cancer.2001Apr20;84(8):1099～1106.
